Suppression of insulin release by calcium antagonist in human insulinoma in vivo and in vitro: its possible role for clinical use.
D000236:Adenoma / Q000378:metabolism*; D007516:Adenoma, Islet Cell / Q000378:metabolism*; D000818:Animals; D002118:Calcium / Q000037:antagonists & inhibitors*; D004110:Diltiazem; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D051381:Rats
D007328:Insulin; D004110:Diltiazem; D002118:Calcium